These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8232004)

  • 1. Is cholesterol testing/treatment really beneficial?
    Barratt A; Irwig L
    Med J Aust; 1993 Nov; 159(10):644-7. PubMed ID: 8232004
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipid lowering in post-MI patients with normal cholesterol.
    Lawless C; Force R
    J Fam Pract; 1997 Jan; 44(1):30. PubMed ID: 9010366
    [No Abstract]   [Full Text] [Related]  

  • 3. Lovastatin to prevent acute coronary events with average cholesterol levels.
    MacFarlane LL; Carek PJ
    J Fam Pract; 1998 Aug; 47(2):91-2. PubMed ID: 9722787
    [No Abstract]   [Full Text] [Related]  

  • 4. [Current developments in prevention of coronary heart disease].
    Windler E
    Z Arztl Fortbild (Jena); 1996 Feb; 90(1):7-10. PubMed ID: 8650967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Statins in primary prevention of coronary heart disease].
    Paulweber B
    Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol and coronary heart disease: screening and treatment.
    Turner-Boutle M
    Nurs Times; 1998 Apr 15-21; 94(15):46-7. PubMed ID: 9615661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesterol lowering, sudden cardiac death and mortality.
    de Lorgeril M; Salen P
    Scand Cardiovasc J; 2008 Aug; 42(4):264-7. PubMed ID: 18615354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of statins in primary prevention: from the theoretical presuppositions to complex scenarios of the real world].
    Poli A; Menotti A
    G Ital Cardiol; 1999 Oct; 29(10):1123-30. PubMed ID: 10546121
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypercholesterolemia: a reversible risk factor for coronary heart disease.
    Mishkel MA
    CMAJ; 1989 Feb; 140(4):419. PubMed ID: 2644008
    [No Abstract]   [Full Text] [Related]  

  • 10. Secondary prevention in coronary heart disease. Fact: lowering cholesterol saves lives.
    McKenna CJ; Sugrue DD
    Ir Med J; 1995; 88(6):191. PubMed ID: 8575912
    [No Abstract]   [Full Text] [Related]  

  • 11. After the failure of ENHANCEd cholesterol lowering in familial hypercholesterolemia, SEAS of problems with ezetimibe.
    Mascitelli L; Ravnskov U; Pezzetta F; Goldstein MR
    Angiology; 2009; 60(1):127-8; author reply 129-30. PubMed ID: 19049996
    [No Abstract]   [Full Text] [Related]  

  • 12. Guidelines for cholesterol management: recommendations of the National Cholesterol Education Program's Adult Treatment Panel II.
    Grundy SM
    Heart Dis Stroke; 1994; 3(3):123-7. PubMed ID: 8044423
    [No Abstract]   [Full Text] [Related]  

  • 13. Decrease in all-cause and CHD mortality with pravastatin over a broad range of initial cholesterol levels.
    Goodwin L
    J Insur Med; 1998; 30(4):276-7. PubMed ID: 10537938
    [No Abstract]   [Full Text] [Related]  

  • 14. Recent developments in coronary heart disease prevention: the Scandinavian and west of Scotland studies.
    Elam MB; Cushman W; Applegate WB; Heimberg M
    Tenn Med; 1997 May; 90(5):189-92. PubMed ID: 9130876
    [No Abstract]   [Full Text] [Related]  

  • 15. [The 4-S study--a turning point in the cholesterol debate. Work Group Lipids and Atherosclerosis of the Swiss Society for Cardiology].
    Nigg C
    Praxis (Bern 1994); 1995 Dec; 84(51-52):1514-6. PubMed ID: 8571010
    [No Abstract]   [Full Text] [Related]  

  • 16. [The new debate on cholesterol: is the lowest level the best?].
    Olsson AG
    Lakartidningen; 1999 Feb; 96(6):648-52. PubMed ID: 10087815
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical prevention of coronary heart disease through cholesterol-lowering therapy.
    Grundy SM
    Curr Ther Endocrinol Metab; 1997; 6():520-6. PubMed ID: 9174799
    [No Abstract]   [Full Text] [Related]  

  • 18. [The effect of lowering cholesterol on mortality].
    Schmidt JG
    Schweiz Med Wochenschr; 1993 Nov; 123(45):2150-5. PubMed ID: 8266036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treating to meet NCEP-recommended LDL cholesterol concentrations with atorvastatin, fluvastatin, lovastatin, or simvastatin in patients with risk factors for coronary heart disease.
    Hunninghake D; Bakker-Arkema RG; Wigand JP; Drehobl M; Schrott H; Early JL; Abdallah P; McBride S; Black DM
    J Fam Pract; 1998 Nov; 47(5):349-56. PubMed ID: 9834769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence based hypolipidaemic drug treatment.
    Mant A
    Aust Fam Physician; 2000 Jan; 29(1):58-9. PubMed ID: 10721547
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.